首页> 外文期刊>Molecular pharmaceutics >Prodrug Approach for Posterior Eye Drug Delivery: Synthesis of Novel Ganciclovir Prodrugs and in Vitro Screening with Cassette Dosing
【24h】

Prodrug Approach for Posterior Eye Drug Delivery: Synthesis of Novel Ganciclovir Prodrugs and in Vitro Screening with Cassette Dosing

机译:后眼药递送的前药方法:用盒式磁带给药合成新的Ganciclovir前药和体外筛选

获取原文
获取原文并翻译 | 示例
           

摘要

Because of poor ocular drug bioavailability, intravitreal injections have become the gold standard for drug delivery to the posterior eye. The prodrug approach can be used for optimizing the biopharmaceutical properties of intravitreal drugs. The preclinical screening of prodrugs' properties, such as hydrolysis and bioconversion, should be conducted in a resource-efficient way for an extensive set of synthesized compounds with validated methods. Our objective was to explore cassette dosing in in vitro prodrug hydrolysis and bioconversion studies in buffer, vitreous, and retinal pigment epithelium (RPE) homogenate for rapid medium-throughput screening. Moreover, our aim was to correlate the prodrug structure with hydrolytic behavior. We synthesized 18 novel ganciclovir prodrugs and first studied their hydrolysis in aqueous buffer and porcine vitreous in vitro with cassette dosing for 35 h. A method for vitreous homogenate pH equilibration to a physiological level by using buffer and incubation under 5% carbon dioxide was validated. The hydrolysis of the prodrugs was evaluated in porcine RPE homogenate in vitro with cassette dosing, and five prodrugs were assayed individually to examine their bioconversion into ganciclovir in RPE after 2 h. Lastly, the prodrugs' binding to melanin was studied in vitro. The prodrugs showed a wide spectrum of hydrolysis rates, ranging from a few percentages to 100% in the vitreous and RPE; in general, hydrolysis in RPE was faster than in vitreous. Prodrugs with long carbon chains and disubstitution showed lability in the tissue homogenates, whereas prodrugs with branched carbon chains and aromatic groups were stable. All five prodrugs chosen for the bioconversion study in RPE were hydrolyzed into ganciclovir, and their hydrolytic behavior matched results from the cassette mix experiment, supporting the cassette mix approach for hydrolysis and bioconversion studies. None of the prodrugs bound highly to melanin (<50% bound). In conclusion, cassette dosing proved useful for the rapid screening of prodrug hydrolysis and bioconversion properties. Analyzing several compounds simultaneously can complicate the analytics, and thus, choosing the compounds of the cassette mix should be done carefully to avoid mutual interference of the compounds with the results. The methodology and results of the work are applicable in ocular drug research and prodrug design.
机译:由于眼部药物生物利用度差,玻璃体内注射已成为对后眼药递送的金标准。前药方法可用于优化玻璃体内药物的生物制药特性。前药物的性质(例如水解和生物转化)的临床前筛选应以资源有效的方式进行,用于广泛的具有验证方法的合成化合物。我们的目的是探索在体外前药水解和生物增生中的盒式磁带,玻璃体和视网膜颜料上皮(RPE)均匀化合物中的快速中吞吐量筛选。此外,我们的目标是将前药结构与水解行为相关联。我们合成18个新的甘辛洛韦前药,首先用盒式磁带给药35小时,研究了它们在水性缓冲液和猪玻璃体中的水解。通过使用缓冲液将玻璃体均化pH平衡的方法进行验证,并在5%二氧化碳下孵育进行生理水平。通过盒给药在猪RPE匀浆中评价前药的水解,用盒式磁带给药,并单独测定五个前药,以在2小时后将它们的生物转化物中的生物转化物中。最后,在体外研究了前药与黑色素的结合。前药显示出广谱的水解速率,从玻璃体和RPE中的百分比达到100%;通常,RPE的水解比玻璃体更快。具有长碳链和二取代的前药在组织匀浆中表现出可容易性,而具有支链碳链和芳族基团的前药稳定。将RPE中的生物转化研究选择的所有五个前药都被水解为GANCICLOVIR,它们的水解行为与盒式混合物实验的结果匹配,支持盒式混合方法进行水解和生物转化研究。没有高素质的前药均未染成黑色素(<50%的结合)。总之,盒式磁带给料证明了用于快速筛选前药水解和生物转化性能。同时分析几种化合物可以使分析复杂化,因此应小心地选择盒式混合物的化合物以避免化合物与结果相互干扰。该工作的方法和结果适用于眼药性研究和前药设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号